Promoted Content Promoted Content

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual BoothPerrigo Company is dedicated to making lives better by bringing Quality Affordable, Self-Care Products.

            Contact the Supplier

            Lead Product(s): Adapalene

            Therapeutic Area: Dermatology Product Name: Undisclosed

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Undisclosed

            Deal Size: $1,550.0 million Upfront Cash: Undisclosed

            Deal Type: Divestment March 01, 2021

            Details:

            Adapalene Cream indicated for the topical treatment of acne vulgaris in Perrigo Topical Generic Rx Business.

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Risankizumab

            Therapeutic Area: Dermatology Product Name: Skyrizi

            Highest Development Status: Approved Product Type: Large molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable June 04, 2021

            Details:

            This approval, which follows the recent European Commission approval, was based on results showing the single risankizumab 150 mg injection met the primary endpoint and demonstrated bioequivalence to the two injections of the risankizumab 75 mg pre-filled syringe.